ALAB vs ENTG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ALAB demonstrates strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and profitability. The company exhibits exceptional growth momentum with 91.8% YoY revenue growth and 83.6% earnings growth, supported by high margins (75.69% gross, 25.70% net) and a pristine balance sheet with negligible debt (Debt/Equity: 0.02). Despite a high valuation (P/E: 98.61), the intrinsic value estimate of $35.99 and Graham Number of $14.83 suggest significant upside potential if growth is sustained. However, recent insider selling and a bearish technical trend introduce near-term caution. Price trades at a 234.3% premium to fair value estimate ($35.99), limiting near-term upside from a valuation perspective.
ENTG shows bearish fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Concerns include weak profitability or high valuation.
Compare Another Pair
Related Comparisons
ALAB vs ENTG: Head-to-Head Comparison
This page compares Astera Labs, Inc. (ALAB) and Entegris, Inc. (ENTG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.